Your shopping cart is currently empty

6-Trehalose monooleate is a glycolipid employed in creating lipid nanoparticles (LNPs) for ex vivo delivery of immunosuppressants. In a tape-stripping test with isolated rabbit ear skin, LNPs with 6-trehalose monooleate encapsulating cyclosporin A predominantly accumulate in the stratum corneum rather than the epidermis and dermis. Additionally, 6-trehalose monooleate serves as an anti-aggregation agent for proteins.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | 6-Trehalose monooleate is a glycolipid employed in creating lipid nanoparticles (LNPs) for ex vivo delivery of immunosuppressants. In a tape-stripping test with isolated rabbit ear skin, LNPs with 6-trehalose monooleate encapsulating cyclosporin A predominantly accumulate in the stratum corneum rather than the epidermis and dermis. Additionally, 6-trehalose monooleate serves as an anti-aggregation agent for proteins. |
| Synonyms | 6-TMO |
| Molecular Weight | 606.74 |
| Formula | C30H54O12 |
| Cas No. | 338733-38-3 |
| Smiles | O([C@H]1O[C@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.